Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC

PHASE2RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Extensive Stage Lung Small Cell Cancer

Interventions

DRUG

Serplulimab

4.5mg/kg,IV over 30 minutes +/- 10 minutes on day 1. Cycles repeat every 21 days.

RADIATION

Chest Radiation

30Gy-45Gy/QD/3Gy

Trial Locations (1)

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors

lead

Zhejiang Cancer Hospital

OTHER